XAAV
DEAD

Serial Number

79342692

Owner

Oxford Genetics Ltd

Filing Date

Feb 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

XAAV Trademark

Serial Number: 79342692

XAAV is a trademark filed by Oxford Genetics Ltd on February 28, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Oxford Genetics Ltd (12 trademarks)

Medawar Centre,

Entity Type: 99

Trademark Details

Filing Date

February 28, 2022

Registration Date

Not Registered

Goods & Services

Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use; none of the aforesaid being or including cell growth media

Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes; none of the aforesaid being or including cell growth media

Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services; none of the aforesaid services relating to cell growth media

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Sep 2, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 31, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 22, 2023 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 31, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 30, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 30, 2023 ABN2
REFUSAL PROCESSED BY IB
Mar 6, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 13, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 13, 2023 RFRR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 12, 2023 LIMN
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jan 12, 2023 LIME
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 17, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 16, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2022 DOCK
LIMITATION OF GOODS RECEIVED FROM IB
Dec 3, 2022 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Nov 19, 2022 LIMG
APPLICATION FILING RECEIPT MAILED
Jun 21, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 16, 2022 REPR